NEW YORK, NY--(Marketwired - Mar 18, 2014) -  Diaceutics Ltd., a leading international consulting, software and services solutions company, which helps the pharmaceutical and diagnostic industries integrate personalized medicine into their strategies, today announced the company will be hosting a complimentary webinar as part of its Personalized Medicine 2.0 Webinar Series.

Moving Beyond Oncology - Integrating Key Personalized Medicine Learnings Across The Organization will be moderated by Dr. Paul Tunnah, CEO & Founder of pharmaphorum media, and feature guest speaker Scott Rairigh, Global Marketing Leader (CVM), Janssen Diagnostics. Scott will discuss Janssen's DxExcellence Toolkit, developed in conjunction with Diaceutics, and approach to ensure employees understand the key business questions across the development pathways of both the drug and the diagnostic.

The webinar will focus on PM education across the pharmaceutical company -- from the R&D team to regulatory to commercial and public affairs -- how can you ensure corporate knowledge and memory is where it needs to be to optimize PM strategies across the company?

"A significant percentage of pharma's current drug pipeline is targeted, however the general investment in tools and resources to ensure the right skill sets to launch these drugs isn't apparent," said Peter Keeling, CEO of Diaceutics. "The one-size-fits-all ways of thinking are over and adding a diagnostics into the picture also adds a level of complexity. Integrating the right corporate knowledge across all functions of the organization is key for successful targeted therapy launches."

The webinar will be held on Tuesday March 25th at 11 am EDT. Participants will learn:

  • Why a strategic CDx strategy is essential to future Pharma commercialization outside of oncology;
  • How to internally integrate PM design into the development and commercialization plan;
  • Ways to educate global teams efficiently across the organization; and
  • The return on investment of early versus late planning outside of oncology.

Register at
Space is limited

Contact Information:

Mark Reis
Executive Vice President of Business Development and Marketing